<DOC>
	<DOCNO>NCT00563810</DOCNO>
	<brief_summary>This multiple dose study assess safety , tolerability , pharmacokinetics pharmacodynamics investigational new drug .</brief_summary>
	<brief_title>Study Evaluating Safety , Pharmacokinetics , Pharmacodynamics MYO-029</brief_title>
	<detailed_description />
	<criteria>Men age 18 45 year inclusive study day 1 . Elderly men woman age 65 80 year inclusive study day 1 . Women must postmenopausal &gt; = 1 year ( estradiol &lt; 25 pg/mL FSH &gt; 40 mIU/mL ) . Healthy determine investigator basis medical history , physical examination , vital sign , clinical laboratory test result , 12leave electrocardiogram . Elderly subject may stable , nonclinically significant abnormality physical examination , laboratory evaluation . Nonsmoker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Adult</keyword>
	<keyword>Aged</keyword>
</DOC>